Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dalton Expands Cannabinoids Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Dalton Expands Cannabinoids Capabilities

Receives license amendment from Health Canada Cannabis Regulation approving sale of cGMP cannabis derived products to License Holders.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dalton Pharma Services has received a three-year renewal and license amendment from Health Canada under the Cannabis Regulations. This amendment authorizes Dalton to sell cGMP cannabis derived products on a “business-to-business” basis to Federal License holders.
 
With its combined Health Canada cGMP and Cannabis licenses, Dalton is positioned to test, develop, produce, and supply cGMP cannabinoids to support the delivery and commercial success of medical cannabinoid products.
 
“This important milestone enables Dalton to transfer finished cGMP cannabis products to licensed dealers,” said Peter Pekos, chief executive officer, Dalton Pharma. “Dalton’s Health Canada licensed cGMP pharmaceutical manufacturing facility is now supporting the imminent commercial launch of CardiolRx, a high concentration pharmaceutically-produced cannabidiol formulation developed through our exclusive partnership with Cardiol Therapeutics, and providing innovative pharmaceutical cannabis products and services to the medical cannabis industry. Dalton is excited to be able to support the industry-wide need for cGMP compliant cannabis manufacturing capabilities to supply our clients’ products to patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics